Phospho-IKBKB (Y199) Antibody

What is the Phospho-IKBKB (Y199) Antibody and what epitope does it recognize?

Phospho-IKBKB (Y199) antibody is a polyclonal antibody typically generated in rabbits that specifically recognizes IKBKB (IKKβ) when phosphorylated at the tyrosine 199 residue. These antibodies are typically generated using KLH-conjugated synthetic phosphopeptides corresponding to amino acid residues surrounding Y199 of human IKBKB . The antibody undergoes a two-step purification process: first with protein G affinity chromatography, followed by peptide affinity purification with both control and phosphorylated peptides to ensure specificity .

What are the different aliases and nomenclature for IKBKB?

IKBKB is known by multiple names in the scientific literature, which can cause confusion when searching for relevant research:

The gene is designated as IKBKB with UniProt ID O14920 and molecular weight of approximately 86.6 kDa .

How does IKBKB function in normal cellular signaling?

IKBKB functions as a key component of the IKK complex that phosphorylates inhibitors of NF-κB (primarily IκBα at S32 and S36), leading to their polyubiquitination and subsequent degradation by the proteasome. This releases NF-κB, allowing its translocation to the nucleus where it activates hundreds of genes involved in immune response, growth control, and protection against apoptosis .

Recent research has revealed that IKBKB is actually a dual-specificity Ser/Thr kinase that can autophosphorylate at tyrosine residues (including Y169, Y188, and Y199) in addition to its activation loop serines . This dual-specific autophosphorylation is critical for IKBKB's function, particularly for its substrate specificity toward S32/S36 of IκBα .

What are the optimal conditions for using Phospho-IKBKB (Y199) Antibody in Western blotting?

For optimal Western blotting results with Phospho-IKBKB (Y199) antibody:

• Dilution ratio: Most manufacturers recommend 1:500-1:2000 dilution for Western blot applications . Start with 1:1000 and optimize as needed.

• Sample preparation: Treatment with TNF-α (20ng/ml) plus Calyculin A (50nM) for 5 minutes can enhance phosphorylation signal, as demonstrated in HeLa cell lysates .

• Controls: Always include both phosphopeptide-blocked and non-blocked samples to verify antibody specificity . The phosphopeptide competition assay is crucial for confirming that the detected signal is indeed from phospho-Y199 IKBKB.

• Buffer conditions: Use PBS containing 0.09% sodium azide as the antibody buffer .

• Storage: Store antibody in aliquots at -20°C and avoid repeated freeze/thaw cycles to maintain activity .

How can I validate the specificity of Phospho-IKBKB (Y199) Antibody?

Validation of phospho-specific antibodies requires several parallel approaches:

• Phosphopeptide competition: Preincubate the antibody with phosphopeptide (containing phosphorylated Y199) versus non-phosphopeptide. The phosphopeptide should abolish signal in Western blot, ELISA, or IHC applications .

• Phosphatase treatment: Treat half of your sample with lambda phosphatase to remove phosphorylation. A specific phospho-antibody should show diminished signal in the phosphatase-treated sample.

• Stimulation experiments: Compare samples from unstimulated cells versus cells treated with stimuli known to induce IKBKB phosphorylation (e.g., TNF-α plus phosphatase inhibitors) .

• Mutant studies: When possible, use Y199F IKBKB mutant-expressing cells as a negative control. This tyrosine-to-phenylalanine mutation prevents phosphorylation while maintaining protein structure.

What approaches can I use to study Y199 phosphorylation in the context of IKBKB function?

To study the functional significance of Y199 phosphorylation:

• Site-directed mutagenesis: Generate Y199F mutant (phospho-deficient) or Y199E/D (phosphomimetic) versions of IKBKB for functional studies. Note that the Y199F mutation has been shown to significantly reduce IKBKB activity in kinase assays .

• TALEN or CRISPR-based knockin: For precise modification of endogenous IKBKB, consider using TALEN-based approaches as described in the literature for other IKBKB mutations . This ensures physiological expression levels.

• Reconstitution experiments: Utilize IKBKB knockout cells (e.g., ikk2^-/-^ MEFs) and reconstitute with wild-type or Y199F IKBKB to compare functional outcomes .

• Dual phosphorylation analysis: Since IKBKB undergoes autophosphorylation at multiple sites, consider examining phosphorylation at Y169, Y188, and Y199 simultaneously, as these may have coordinated functions .

How does Y199 phosphorylation relate to other regulatory phosphorylation sites in IKBKB?

Y199 phosphorylation appears to be part of a complex phosphorylation network within IKBKB:

What is the role of Y199 phosphorylation in pathological conditions?

Current research has implicated IKBKB dysregulation in several disease contexts:

• Immune deficiency: A gain-of-function mutation in IKBKB (V203I, located near Y199) results in enhanced NF-κB signaling and a combined immune deficiency syndrome with T and B cell functional defects .

• Lymphomas: Mutations in IKBKB (particularly K171E and K171T) have been found in lymphomas that constitutively activate NF-κB signaling .

• Huntington's disease: IKBKB has been identified as a regulator of huntingtin phosphorylation at S13, which reduces huntingtin aggregation. This function depends on IKBKB's kinase activity .

While the specific role of Y199 phosphorylation in these conditions hasn't been fully elucidated, its proximity to disease-associated mutations (e.g., V203I) suggests potential involvement in regulating IKBKB's pathological activities.

How does the dual-specificity nature of IKBKB impact experimental design when studying Y199 phosphorylation?

The discovery that IKBKB is a dual-specificity kinase capable of autophosphorylating at tyrosine residues necessitates careful experimental design:

• Kinase assays: When analyzing IKBKB activity, both serine/threonine and tyrosine phosphorylation should be monitored. Traditional kinase assays may miss tyrosine phosphorylation events.

• Phosphorylation dynamics: The kinetics of tyrosine versus serine phosphorylation may differ. Time-course experiments should capture both rapid and delayed phosphorylation events.

• Phosphatase considerations: Dual-specificity phosphatases versus tyrosine-specific or serine/threonine-specific phosphatases may differently regulate IKBKB. Research has implicated PP2A in regulating IKBKB's ability to modulate phosphorylation levels .

• Structural biology approaches: When interpreting structural data, consider that the DFG+1 position (Y169 in IKBKB) is crucial for determining substrate specificity . Y199's structural relationship to this position may provide insights into its regulatory function.

What are common issues when detecting phospho-Y199 IKBKB and how can they be resolved?

Researchers frequently encounter these challenges:

• Low signal intensity:

  • Solution: Enrich for phosphoproteins using phosphotyrosine immunoprecipitation before Western blotting

  • Use signal enhancers like TNF-α (20ng/ml) plus Calyculin A (50nM)

  • Optimize primary antibody concentration and incubation time

• High background:

  • Solution: Increase blocking time and washing steps

  • Use peptide competition to confirm specificity

  • Consider alternative blocking agents (BSA vs. milk)

• Cross-reactivity:

  • Solution: Always validate with phosphopeptide competition assays

  • Include Y199F mutant samples as negative controls

  • Use phosphatase-treated samples as additional controls

• Inconsistent results:

  • Solution: Standardize cell stimulation protocols (timing is critical)

  • Immediately add phosphatase inhibitors to lysis buffers

  • Maintain consistent experimental conditions across replicates

How can I differentiate between monomeric IKBKB and IKK complex-dependent phosphorylation of Y199?

This distinction is important since recent research shows that monomeric and NEMO binding-incompetent IKBKB remain capable of certain functions independent of the IKK complex :

• NEMO-binding domain mutations: Create NBD mutants of IKBKB that cannot bind NEMO and assess Y199 phosphorylation.

• Comparative analysis: Compare IKBKB, IKBKA, and IKBKE for their ability to phosphorylate at Y199, as research shows these kinases have different dependencies on the IKK complex .

• Size exclusion chromatography: Separate monomeric, dimeric, and complex-bound IKBKB and assess Y199 phosphorylation status in each fraction.

• Subcellular fractionation: Since different pools of IKBKB may exist in different cellular compartments, analyze Y199 phosphorylation in cytoplasmic versus membrane versus nuclear fractions.

What considerations are important when studying Y199 phosphorylation across different model systems?

Cross-species and cross-system considerations include:

• Conservation analysis: The Y199 site appears to be conserved across human, mouse, and rat IKBKB , allowing for translational research between these models.

• Isoform considerations: Verify IKBKB isoform expression in your model system, as alternative splicing might affect the region containing Y199.

• Cell-type specificity: Phosphorylation patterns may vary between cell types. IKK2 activation in lymphocytes versus epithelial cells may involve different regulatory mechanisms .

• Signal strength differences: The threshold for detecting Y199 phosphorylation may differ between cell types and may require optimization of stimulation conditions.

• Species-specific antibody validation: Even though the sequence around Y199 is conserved, always validate antibody specificity when switching between human, mouse, and rat samples.

How might Y199 phosphorylation contribute to the phosphate relay mechanism in IKBKB?

Recent groundbreaking research has revealed that IKBKB can directly transfer phosphate groups to IκBα through a phosphate relay mechanism:

• Relay mechanism: Auto-phosphorylated IKK2 can transfer phosphate group(s) to IκBα in the presence of ADP without requiring ATP . This represents a novel mechanism in eukaryotic protein kinase function.

• Y169 vs. Y199 roles: While Y169 has been identified as potentially critical in this relay (due to its position at the DFG+1 site), Y199 may also participate in or regulate this process .

• Experimental approach: To test Y199's role in phosphate relay:

  • Generate Y199F mutants alongside Y169F mutants

  • Compare their ability to phosphorylate IκBα in ADP-only conditions

  • Use mass spectrometry to detect phosphate transfer dynamics

• Evolutionary implications: This unusual mechanism appears to be specific to IKK1 and IKK2, not present in other closely related kinases like IKKε and TBK1 , suggesting specialized evolutionary adaptations.

What are the implications of Y199 phosphorylation for targeted therapeutics?

Understanding Y199 phosphorylation could lead to novel therapeutic approaches:

• Selective inhibition: Most current IKK inhibitors target the ATP-binding site. Y199-specific interactions might offer alternative targeting strategies with potentially different downstream effects.

• Phosphorylation-state specific inhibitors: Compounds that specifically recognize and inhibit Y199-phosphorylated IKBKB might selectively target activated pools of the kinase.

• Disease context: In conditions like the combined immune deficiency syndrome caused by gain-of-function IKBKB mutations , targeting Y199 phosphorylation might provide therapeutic benefit.

• Huntington's disease applications: Since IKBKB has been shown to reduce huntingtin aggregation through phosphorylation , enhancing Y199 phosphorylation might have therapeutic potential in neurodegenerative disorders.

How might phosphorylation at Y199 affect IKBKB's selectivity for IκBα versus other substrates?

The exquisite specificity of IKBKB for S32/S36 of IκBα appears to involve multiple mechanisms:

• Substrate discrimination: Research suggests that Y169 (the DFG+1 residue) helps distinguish between serine versus threonine residues . Y199 may similarly contribute to substrate selection.

• Digital activation profile: The all-or-none activation profile of NF-κB may be linked to the phosphate relay process and specific tyrosine phosphorylation events within IKBKB .

• Experimental approaches:

  • Compare phosphorylation rates of various IKBKB substrates in cells expressing WT versus Y199F IKBKB

  • Use phosphoproteomics to identify differential substrate targeting in dependence of Y199 phosphorylation

  • Perform structural modeling to understand how Y199 phosphorylation might alter substrate binding pocket conformation

How can researchers ensure reproducible detection of Y199 phosphorylation across different experimental systems?

Ensuring reproducibility requires standardization of multiple parameters:

• Antibody validation standards:

  • Implement rigorous validation with phosphopeptide competition

  • Establish minimum signal-to-noise thresholds

  • Document lot-to-lot variability

• Stimulation protocols:

  • Standardize concentration and duration of stimuli (e.g., TNF-α)

  • Define optimal time points for capturing transient phosphorylation

  • Consider cell density effects on signaling

• Quantification approaches:

  • Normalize phospho-signals to total IKBKB

  • Use internal loading controls consistently

  • Apply appropriate statistical tests for phosphorylation changes

• Reporting standards:

  • Document complete antibody information (catalog number, lot, dilution)

  • Specify exact cell types, passage numbers, and treatment conditions

  • Include all controls in publications, even negative results

What are the best methods to distinguish Y199 phosphorylation from other tyrosine phosphorylation events in IKBKB?

Distinguishing between different phosphorylation sites requires specialized approaches:

• Mass spectrometry strategies:

  • Targeted MS approaches focusing on specific phosphopeptides

  • Parallel reaction monitoring (PRM) for quantitative analysis

  • Phosphopeptide enrichment before MS analysis

• Multiplex antibody approach:

  • Use multiple phospho-specific antibodies targeting different sites

  • Employ phospho-flow cytometry for single-cell analysis

  • Develop multiplex Western blotting protocols

• Mutational analysis matrix:

  • Create single and combinatorial Y→F mutations (Y169F, Y188F, Y199F)

  • Test functional outcomes of each combination

  • Map interdependencies between different phosphorylation sites

• Structural biology approaches:

  • Crystal structures with phosphomimetic mutations

  • Hydrogen-deuterium exchange mass spectrometry to detect conformational changes

  • NMR studies of phosphorylation-dependent conformational dynamics